Largest biotech companies by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Amgen leads the 24 biotech companies ranked by total assets, at HUF 30.45T, ahead of Gilead Sciences (HUF 19.84T) and Biogen (HUF 9.9T). Figures as of 18 Nov 2026, 16:47 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- First
- AmgenHUF 30.45T
- Median
- HUF 859.2B
- Combined market value
- HUF 282.53T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | HUF 30.45T | HUF 81.26T | HUF 150,227.12 | 2.41% down | 34% up | ||
| 2 | Gilead SciencesGILD · Health Care | HUF 19.84T | HUF 70.61T | HUF 56,925.32 | 0.54% down | 33% up | ||
| 3 | BiogenBIIB · Health Care | HUF 9.9T | HUF 12.42T | HUF 84,019.01 | 0.34% down | 49% up | ||
| 4 | BioNTechBNTX · Health Care | HUF 8.2T | HUF 7.01T | HUF 28,283.66 | 0.85% down | 16% down | ||
| 5 | ModernaMRNA · Health Care | HUF 4.15T | HUF 27.5T | HUF 67,971.21 | 2.22% down | 755% up | ||
| 6 | argenxARGX · Health Care | HUF 2.92T | HUF 19.91T | HUF 316,602.88 | 0.60% down | 4% up | ||
| 7 | QiagenQGEN · Health Care | HUF 2.11T | HUF 3.44T | HUF 16,652.87 | 0.42% down | 12% up | ||
| 8 | Neurocrine BiosciencesNBIX · Health Care | HUF 1.56T | HUF 5.53T | HUF 54,671.44 | 1.98% down | 20% up | ||
| 9 | VaxcytePCVX · Health Care | HUF 1.01T | HUF 3.13T | HUF 19,795.87 | 0.86% down | 22% up | ||
| 10 | RepligenRGEN · Health Care | HUF 991.5B | HUF 3.65T | HUF 57,108.52 | 4.75% up | 5% up | ||
| 11 | ExelixisEXEL · Health Care | HUF 956.2B | HUF 5.67T | HUF 23,220.57 | 0.84% up | 63% up | ||
| 12 | Bio-TechneTECH · Health Care | HUF 869.5B | HUF 3.84T | HUF 24,446.51 | 0.13% up | 26% up | ||
| 13 | Halozyme TherapeuticsHALO · Health Care | HUF 848.9B | HUF 3.72T | HUF 32,589.74 | 1.02% up | 37% up | ||
| 14 | Revolution MedicinesRVMD · Health Care | HUF 791.5B | HUF 11.61T | HUF 53,676.43 | 1.85% down | 131% up | ||
| 15 | CRISPR TherapeuticsCRSP · Health Care | HUF 761.5B | HUF 1.36T | HUF 13,975.17 | 3.55% up | 21% down | ||
| 16 | Kymera TherapeuticsKYMR · Health Care | HUF 585.8B | HUF 3.46T | HUF 40,499.35 | 0.86% down | 87% up | ||
| 17 | Krystal BiotechKRYS · Health Care | HUF 448.4B | HUF 3.1T | HUF 104,466.18 | 4.09% up | 46% up | ||
| 18 | ImmunovantIMVT · Health Care | HUF 321.7B | HUF 2.33T | HUF 11,264.39 | 0.90% up | 43% up | ||
| 19 | CG OncologyCGON · Health Care | HUF 266.1B | HUF 2.43T | HUF 27,171.00 | 2.39% up | 85% up | ||
| 20 | Twist BioscienceTWST · Health Care | HUF 215.8B | HUF 2.64T | HUF 38,677.42 | 2.73% up | 340% up | ||
| 21 | Adaptive BiotechnologiesADPT · Health Care | HUF 172.4B | HUF 1.53T | HUF 9,442.45 | 1.40% down | 88% up | ||
| 22 | ImmunityBioIBRX · Health Care | HUF 168.7B | HUF 2.35T | HUF 2,213.55 | 5.19% up | 193% up | ||
| 23 | Scholar Rock HoldingSRRK · Health Care | HUF 135.9B | HUF 1.92T | HUF 15,762.07 | 4.02% up | 14% up | ||
| 24 | Kodiak SciencesKOD · Health Care | HUF 118.2B | HUF 2.12T | HUF 32,405.70 | 0.41% down | 396% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 336.1 HUF).
Questions and answers
Which biotech companies rank first by total assets?
Amgen (HUF 30.45T), Gilead Sciences (HUF 19.84T) and Biogen (HUF 9.9T) are the top three of the 24 biotech companies ranked by total assets as of 18 Nov 2026, 16:47 UTC.
How many biotech companies are in this ranking?
24 are ranked by total assets.
What are these biotech companies worth together?
The 24 biotech companies ranked by total assets have a combined market value of HUF 282.53T as of 18 Nov 2026, 16:47 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by total assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.